Sunday, April 25, 2010

Smith & Nephew Inc. Receives FDA 510k Clearance for a 30-year Knee

›
MEMPHIS, Tenn., April 22 /PRNewswire-FirstCall/ -- As evidence of its drive to return knee pain sufferers to a lifetime of physical activi...

Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years

›
Company Showcases Expanded Portfolio at ASAPS WASHINGTON, April 23 (HSMN NewsFeed) -- Following news of the acquisition of BioForm Medic...

Flexuspine Receives FDA Conditional Approval to Begin a Feasibility Study of Its FSU (Functional Spinal Unit) Total Spine Arthroplasty System in the U

›
PITTSBURGH, April 22 (HSMN NewsFeed) -- Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted ...

PureGraft Enters the Market as an Innovative New System for Safe, Fast and Reliable Fat Graft Processing

›
SAN DIEGO--(HSMN NewsFeed)--Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardiz...

Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board

›
BOSTON, April 22 (HSMN NewsFeed) -- Boston-based medical technology firm Gelesis, Inc. unveiled its capsulated device Attiva™, and pres...

Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram

›
New Technology 100% Radiation-Free ALBUQUERQUE, N.M.--(HSMN NewsFeed)--Manhattan Scientifics, Inc. (OTCBB: MHTX ) announced today that its...
Wednesday, April 21, 2010

Delcath Phase III Trial Results Exceed Primary Endpoint Expectations

›
Treatment Arm Shows More Than 3x Median hPFS Compared to Control Arm New York, NY -- April 21, 2010 -- Delcath Systems, Inc. (NASDAQ: DCTH...

Medtronic Receives FDA Approval for New Indication for Complete(R) SE Vascular Stent

›
Now Indicated for Treatment of Peripheral Disease in the Iliac Arteries, Self-Expanding (SE) Device Redefines Deployment Accuracy for Prec...

Medtronic Completes Acquisition of Invatec and Affiliated Companies

›
Acquisition Expands Product Offering and Pipeline for Cardiovascular Interventions MINNEAPOLIS, April 21--(HSMN NewsFeed)--Moving to expan...

Proteus Announces FDA Clearance of Wireless Personal Health Monitor

›
Company Also Completes Financing with Leading Medical Device, Pharmaceutical and Semiconductor Companies as Investors REDWOOD CITY, Calif....

LDR is the First to Announce Completion of Two-year Follow-Up on a Two-Level Cervical Artificial Disc IDE Study

›
LDR prepares PMA submission for FDA review of the Mobi-C® cervical artificial disc AUSTIN, Texas--(HSMN NewsFeed)--LDR, a privately held c...

Endosense Launches Next Generation TactiCath(R) Force-Sensing Catheter

›
GENEVA, April 20--(HSMN NewsFeed)--Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility ...

AngioDynamics Announces First Patient Treatment and Ongoing Enrollment in the Clinical Trial of the Use of IRE Technology in the Treatment of Early St

›
Seven Medical Centers in Europe to Participate in Clinical Trial QUEENSBURY, N.Y.--(HSMN NewsFeed)--AngioDynamics (NASDAQ:ANGO ) today anno...

Covidien Announces Innovation: Delivered Mobile Surgical Tour

›
Initiative Brings Single-Incision Laparoscopic Device and Groundbreaking Procedures to Surgeons around the Country NORTH HAVEN, Conn.--(HS...

Interventional Spine, Inc. Announces the First US Implant of RENEW(TM), Interspinous Allograft Technology for the Treatment of Lumbar Spinal Stenosis

›
IRVINE, Calif., April 19 (HSMN NewsFeed) -- Interventional Spine, Inc. today announced the first commercial implant in the United State...
1 comment:

Contura Submits Registration Application for Aquamid(R) to the FDA

›
SOBORG, Denmark, April 15 (HSMN NewsFeed) -- Contura Inc. has submitted a Premarket Approval Application (PMA) for Aquamid® to the U.S...

Fraxel re:store(R) Dual Laser Proven Effective in Treating Actinic Keratoses, a Common Precancerous Skin Condition

›
Fraxel re:store Treatment Removes Actinic Keratoses and Improves the Overall Appearance of Skin HAYWARD, Calif., April 15 (HSMN NewsFeed)...
1 comment:

Smith & Nephew Expands ACTICOAT(TM) Product Portfolio

›
Customer input drives introduction of ACTICOAT Flex 7 Ribbon and ACTICOAT Post Op Line Extension ST. PETERSBURG, Fla., April 15 (HSMN New...

Salient Surgical Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market

›
Benefits of TRANSCOLLATION(TM) Technology Brought to Pelvic Fracture, Hip and Acetabulum Fracture, Amputation, Osteotomy and Debridement P...

Varian Medical Systems Introduces Revolutionary New TrueBeam(TM) System for High-Precision Image-Guided Radiotherapy and Radiosurgery

›
New technology enables a radical new approach that expands radiotherapy treatment options for even the most challenging cases NEW YORK, Ap...
Friday, May 1, 2009

ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

›
Largest Study to Date Will Evaluate SilverHawk Plaque Excision System for Treatment of Lower Extremity Peripheral Arterial Disease PLYMOUTH,...

FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R)

›
OR AKIVA, Israel, April 28 (HSMN NewsFeed) -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and ...

Gore Announces Availability of Larger Diameter, Small Profile GORE EXCLUDER AAA Endoprosthesis

›
Minimally Invasive Treatment Now Available to Broader Patient Population FLAGSTAFF, Ariz.--(HSMN NewsFeed)--W. L. Gore & Associates (Gor...

Study Finds Cook Medical Resonance Metallic Ureteral Stent Provides 43 Percent Cost Savings

›
Presentation at 2009 AUA Conference Highlights Success of Stent in Cost-Effectively Treating Benign Ureteral Obstruction BLOOMINGTON, Ind.--...

First Ever Prospective Fracture Study in Prostate Cancer Patients on ADT Reveals These Men Are at High Risk for Skeletal Fractures

›
Data from GTx’s Phase III clinical trial evaluating toremifene 80 mg for the prevention of fractures in men with prostate cancer on androgen...